Hypertension

• 1235.37.01 Boehringer Ingelheim Investigational Site — Chuo-ku,Tokyo, Japan
• 1235.37.07 Boehringer Ingelheim Investigational Site — Hiroshima, Hiroshima, Japan
• 1235.37.08 Boehringer Ingelheim Investigational Site — Itoshima, Fukuoka, Japan
• 1235.37.02 Boehringer Ingelheim Investigational Site — Katsushika-ku, Tokyo, Japan

• 1235.5.32004 Boehringer Ingelheim Investigational Site — Aywaille, Belgium
• 1235.5.32001 Boehringer Ingelheim Investigational Site — Brussels, Belgium
• 1235.5.32010 Boehringer Ingelheim Investigational Site — Gozée, Belgium
• 1235.5.32008 Boehringer Ingelheim Investigational Site — Linkebeek, Belgium

• 1235.16.004 Boehringer Ingelheim Investigational Site — Chofu, Tokyo, Japan
• 1235.16.006 Boehringer Ingelheim Investigational Site — Nishi-ku, Hiroshima, Hiroshima, Japan
• 1235.16.005 Boehringer Ingelheim Investigational Site — Osaka, Osaka, Japan
• 1235.16.007 Boehringer Ingelheim Investigational Site — Osaka, Osaka, Japan

• 502.550.01008 Boehringer Ingelheim Investigational Site — Athens, Alabama, United States
• 502.550.01019 Boehringer Ingelheim Investigational Site — Mobile, Alabama, United States
• 502.550.01015 Boehringer Ingelheim Investigational Site — Lomita, California, United States
• 502.550.01003 Boehringer Ingelheim Investigational Site — Colorado Springs, Colorado, United States

• 1235.36.01 Boehringer Ingelheim Investigational Site — Chuo-ku,Tokyo, Japan
• 1235.36.04 Boehringer Ingelheim Investigational Site — Hiroshima, Hiroshima, Japan
• 1235.36.02 Boehringer Ingelheim Investigational Site — Shinjuku-ku, Tokyo, Japan
• 1235.36.03 Boehringer Ingelheim Investigational Site — Suita, Osaka, Japan

Not specified

• Department of Cardiology, West China Hospital, Sichuan University — Chengdu, Sichuan, China

Not specified

• Ebina, Kanagawa, Japan
• Sagamihara, Kanagawa, Japan
• Kawaguchi, Saitama, Japan
• Shinjuku, Tokyo, Japan

• University of Florida — Gainesville, Florida, United States